Genocea Biosciences Announces Closing Of Initial Public Offering
2/10/2014 10:02:22 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. today announced the closing of its initial public offering of 5,500,000 shares of its common stock at a public offering price of $12.00 per share. After underwriting discounts and commissions and estimated offering expenses, Genocea received net proceeds of approximately $61.4 million, excluding estimated offering expenses. The shares are listed on the NASDAQ Global Market under the ticker symbol “GNCA."
Help employers find you! Check out all the jobs and post your resume.
comments powered by